Rearranged during transfection (RET) is a proto oncogene implicated in thyroid carcinogenesis of papillary type (PTC). The RET proto-oncogene in PTC is constitutively activated by fusion of its tyrosine kinase domain with the 5 ´region of another gene thereby generating chimeric products collectively named RET/PTCs. RET/PTC1 and RET/PTC3 are best characterized among all RET/PTC rearrangements. Kashmir valley has witnessed an alarming increase in thyroid cancer incidence in young women. Therefore, we investigated the occurrence of RET/PTC 1 & 3 rearrangements by semi quantitative and qPCR in thyroid cancer patients (n = 48) of Kashmiri population and interrelated results with various clinicopathological characteristics. We observed that all the RET/PTC rearrangements were confined to PTC cases (10/40). Presence of RET/PTC rearrangement significantly correlated with gender, elevated TSH levels and lymph node metastasis. Overall, our study advocates that RET/PTC3 rearrangement is a frequent event in the carcinogenesis of thyroid gland in Kashmiri population although a study with a larger sample size is needed to get a clear scenario.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12253-018-0540-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review.
J Transl Med
November 2024
Dipartimento delle Scienze Mediche, Motorie e del Benessere, Università Degli Studi di Napoli Parthenope, Naples, Italy.
Background: There is a growing interest on the association of radiomic features with genomic signatures in oncology. Using computational methods, quantitative radiomic data are extracted from various imaging techniques and integrated with genomic information to construct predictive models aimed at advancing diagnostic strategies in cancer patient management. In this context, the aim of this systematic review was to assess the current knowledge on potential application of this association in patients with thyroid cancer (TC).
View Article and Find Full Text PDFThe role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer.
Front Oncol
November 2024
Clinical Biochemistry Unit, Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Thyroid cancer (TC) is the most common endocrine cancer, which contributes to more than 43,600 deaths and 586,000 cases worldwide every year. Among the TC types, PTC and FTC comprise 90% of all TCs. Genetic modifications in genes are responsible for encoding proteins of mitogen-associated protein kinase cascade, which is closely related with numerous cellular mechanisms, including controlling programmed cell death, differentiation, proliferation, gene expression, as well as in genes encoding the PI3K (phosphatidylinositol 3-kinase)/protein kinase B (AKT) cascade, which has contribution in controlling cell motility, adhesion, survival, and glucose metabolism, have been associated with the TC pathogenesis.
View Article and Find Full Text PDF[Correlations of Ultrasound Features With Gene Mutations and Pathologic Subtypes in Papillary Thyroid Carcinoma].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
October 2024
Department of Ultrasound, China-Japan Friendship Hospital,Beijing 100029,China.
The prognosis of papillary thyroid carcinoma (PTC) is highly dependent on gene mutations and pathologic features.The common gene mutations in PTC include BRAF V600E,RET/PTC rearrangement,and RAS mutations.These mutations have been suggested to be associated with an increased risk of recurrence,poorer efficacy of postoperative radioactive iodine therapy,and reduced survival.
View Article and Find Full Text PDFConcomitant BRAF V600E and NRAS Q61R mutations in the same thyroid nodule: a case report.
AME Case Rep
July 2024
Pathology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy.
Article Synopsis
- Papillary thyroid cancer (PTC) is the most common type of thyroid cancer and usually has specific mutations that are not found together.
- A case involved a 46-year-old woman with a neck mass who had both BRAF and NRAS mutations in different parts of the same thyroid lobe, which is unusual.
- Finding these two mutations together suggests that even within one tumor, there can be different characteristics, and it might mean a more serious form of cancer that could affect treatment options.
Objective: Ionizing radiation generates genomic instability by promoting the accumulation of chromosomal rearrangements. The oncogenic translocation RET/PTC1 is present in more than 70% of radiation-induced thyroid cancers. Both RET and CCDC6, the genes implicated in RET/PTC1, are found within common fragile sites - chromosomal regions prone to DNA breakage during slight replication stress.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!